PIMA541716
Omalizumab Recombinant Human Monoclonal Antibody, Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | PIMA541716-Each-of-1 | In Stock | ₹ 45,790.50 |
PIMA541716 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 45,790.50
GST (18%): ₹ 8,242.29
Total Price: ₹ 54,032.79
Antigen
Omalizumab
Classification
Recombinant Monoclonal
Conjugate
Unconjugated
Gene Alias
IGE25; olizumab; pSVIE26; rhuMab-E25; Xolair
Immunogen
Human IGHE
Quantity
100 μg
Primary or Secondary
Primary
Content And Storage
-20° C, Avoid Freeze/Thaw Cycles
Form
Liquid
Target Molecule
Chemical
Applications
ELISA, SDS-Page
Concentration
3.42 mg/mL
Formulation
PBS with no preservative; pH 7.5
Host Species
Human
Purification Method
Protein A
Regulatory Status
RUO
Target Species
Chemical
Product Type
Antibody
Isotype
IgG1 κ
Related Products
Description
- Endotoxin level < 0.01EU/μg by LAL method Use a manual defrost freezer and avoid repeated freeze thaw cycles
- Store at 2 to 8 °C for one week
- Store at -20 to -80 °C for twelve months from the date of receipt
- Omalizumab with trade name Xolair, is an FDA-approved drug for the treatment of moderate to severe persistent asthma in adults and adolescents (12 years of age and above)
- It is a recombinant humanized monoclonal antibody
- It selectively binds to human immunoglobulin E (IgE)
- Omalizumab inhibits the binding of IgE to the high-affinity IgE receptor (FcERI) on the surface of mast cells and basophils.